# Contact Safe Wolverine: Editorial Inquiries on the BPC-157 TB-500 Digest

> Contact Safe Wolverine about the BPC-157 TB-500 editorial digest — corrections, citation questions, and editorial inquiries. Not a clinic; no medical advice or sales.

Corrections, citation questions, and editorial inquiries about the matchup. We do not provide medical advice and we do not sell anything.

## Editorial inquiries only

Use this page for editorial inquiries about the BPC-157 TB-500 digest: a correction to a citation, a study we should add, or a question about how we read the record. We read every message, and we update pages when a sourced correction is warranted.

What this desk cannot do: it cannot give medical advice, recommend a dose, evaluate your situation, or help you obtain any substance. We are not a clinic and not a vendor, and we have no clinical staff. For anything involving your health, consult an appropriately licensed healthcare professional.

## What we cover

Safe Wolverine summarizes the peer-reviewed literature and the FDA compounding record on the two-peptide Wolverine blend — BPC-157 in one corner, TB-500 in the other — and keeps the combination's missing data and the regulatory status in plain sight. If your message is about the research or the access record, you are in the right place. The form below collects only what we need to reply: a name, an email, and your message.

---

A versus-screen reading of the BPC-157 TB-500 blend — each peptide racked against its own studies, the combination row left at NO MATCH ON RECORD, and the FDA and WADA status called before the bell, with no clinic in the corner and nothing here for sale.